Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.
Watch the show on television by downloading the e360tv channel app to your Roku, LG or AmazonFireTV. You can also see it on YouTube.
Devin: What is your superpower?
Eugene: Staying focused on a North Star.
Eugene Chan, CEO and founder of rHEALTH, has taken blood diagnostics to new heights—literally. His innovative technology, capable of analyzing dozens of biomarkers from a single drop of blood, was tested aboard the International Space Station (ISS). In today’s episode, Eugene shared the remarkable journey of rHEALTH, from competing with top companies for a NASA partnership to launching its device into space.
What sets rHEALTH apart is its proven reliability in extreme conditions, including the zero-gravity environment of space. Eugene explained, “We tested this technology on the International Space Station with astronaut Samantha Cristoforetti, who operated the device and obtained precise values from single drops of sample. They did the analysis using our device and got absolutely the right answers.” This achievement underlines the robustness and accuracy of rHEALTH’s technology, qualities that distinguish it from other attempts at single-drop blood diagnostics.
Unlike Theranos, which famously failed to deliver on similar promises, rHEALTH’s technology has been rigorously vetted. Eugene highlighted the grueling process of earning NASA’s trust. “To be the one company selected to demonstrate our novel technology on the ISS was a huge undertaking,” he said. He recounted the intense competition and NASA’s exacting standards, which included testing the device’s functionality during zero-gravity parabolic flights.
Now, Eugene and his team are bringing this groundbreaking technology to the public with a regulated crowdfunding campaign on StartEngine. “You don’t have to be a Silicon Valley elite or a Boston venture capitalist to participate,” I noted during the episode. With this campaign, everyday investors have the opportunity to support a proven technology poised to revolutionize healthcare.
The implications of rHEALTH’s success are profound. If it works in space, it can work in remote clinics, underserved communities, and even in people’s homes. This technology has the potential to make diagnostics more accessible, empowering individuals to take control of their health.
Eugene’s vision, combined with rHEALTH’s proven track record, makes this an exciting investment opportunity. Visit StartEngine to learn more and become part of this revolutionary journey.
tl;dr:
Eugene Chan shared how rHEALTH’s diagnostic technology was tested and proven aboard the International Space Station.
He explained the rigorous process of competing with other companies to secure NASA’s trust.
rHEALTH’s crowdfunding campaign on StartEngine makes investing in this revolutionary technology accessible to all.
Eugene highlighted the importance of his North Star: improving human health with innovative solutions.
He shared advice on maintaining focus and using challenges as opportunities to achieve big goals.
How to Develop Staying Focused on a North Star As a Superpower
Eugene’s superpower is his ability to maintain a relentless focus on his “North Star”—the overarching goal of improving human health. As he explained, “The North Star has always been to improve the human condition and help us improve human health.” For Eugene, this guiding principle has driven his work through challenges, from competing for NASA’s attention to developing groundbreaking diagnostic technology.
One illustrative story of this superpower came during a pivotal moment in Eugene’s career. While competing in the XPRIZE competition, he found himself grappling with a flawed prototype. It was during this time, sitting at his wife’s bedside after the birth of their child, that the concept for rHEALTH’s current device was born. Combining the pressure of the competition, the inspiration of his newborn daughter, and his unwavering focus on creating a robust solution, Eugene developed the technology that would later achieve success in space.
Eugene also shared actionable tips for developing this superpower:
Identify your personal North Star—a goal or mission that deeply resonates with you.
Let that North Star guide your decisions, especially during challenging times.
Stay committed to your mission, even when facing setbacks or obstacles.
Use external pressures, like deadlines or competitions, to fuel innovation and progress.
By following Eugene’s example and advice, you can make staying focused on a North Star a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.
Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!
Guest Profile
Eugene Chan (he/him):
CEO, Founder, rHEALTH
About rHEALTH: rHEALTH has worked with NASA to develop a miniaturized diagnostic test system to keep astronauts healthy on the way to Mars. We have successfully tested this on board the International Space Station and published the results in Nature Communications, demonstrating results from blood in minutes in extreme environments. The technology shrinks a central clinical lab and a team of doctors in a form suitable for everyday use. Comprehensive lab-quality analysis can be performed by anyone, fundamentally shifting diagnostics from centralized facilities to the point-of-care and homes. The focus is to usher in Diagnostics 2.0, allowing high-value multiplexed diagnostics.
Website: rhealth.com
Other URL: startengine.com/offering/rhealth
Biographical Information: Dr. Chan is a physician-inventor. He is currently Founder, CEO of rHEALTH, and President, CSO of DNA Medicine Institute, a medical innovation laboratory. He has been honored as Esquire magazine’s Best and Brightest, one of MIT Technology Review’s Top 100 Innovators, and an XPRIZE winner. His work has contributed to the birth of next-generation sequencing, health monitoring in remote environments, and therapeutics. Dr. Chan holds over 60 patents and publications, with work funded by the NIH, NASA, and USAF. Dr. Chan received an A.B. in Biochemical Sciences from Harvard College summa cum laude in 1996, received an M.D. from Harvard Medical School with honors in 2007, and trained in medicine at the Brigham and Women’s Hospital. He has been in zero gravity and led the team that demonstrated the rHEALTH ONE bioanalyzer onboard the International Space Station.
LinkedIn Profile: linkedin.com/in/eugene-chan-4220045
Personal Twitter Handle: @Dr_EugeneChan
Bold Awards—Voting Ends Today!
The Super Crowd, Inc. has been nominated for a BOLD Award in the Media/AdTech category, an international recognition for innovative platforms advancing the future of business and society. Finalists are selected in large part through public voting, making community support genuinely influential.
If you believe in independent media that elevates impact capital, diverse founders, and social good, I’d be grateful if you’d consider voting. The process does require setting up an account and rating us in four areas (1–10), so I’ve recorded a one-minute video to walk you through it.
Your vote helps ensure this work—and the founders it serves—gets the visibility it deserves. Thank you for taking the time.
Support Our Sponsors
Our generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today’s advertisers include Crowdfunding Made Simple. Learn more about advertising with us here.
Max-Impact Members
(We’re grateful for every one of these community champions who make this work possible.)
Brian Christie, Brainsy | Cameron Neil, Lend For Good | Carol Fineagan, Independent Consultant | Hiten Sonpal, RISE Robotics | John Berlet, CORE Tax Deeds, LLC. | Justin Starbird, The Aebli Group | Lory Moore, Lory Moore Law | Mark Grimes, Networked Enterprise Development | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Mike Green, Envirosult | Dr. Nicole Paulk, Siren Biotechnology | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Scott Thorpe, Philanthropist | Sharon Samjitsingh, Health Care Originals | Add Your Name Here
Upcoming SuperCrowd Event Calendar
If a location is not noted, the events below are virtual.
SuperGreen Live, January 22–24, 2026, livestreaming globally. Organized by Green2Gold and The Super Crowd, Inc., this three-day event will spotlight the intersection of impact crowdfunding, sustainable innovation, and climate solutions. Featuring expert-led panels, interactive workshops, and live pitch sessions, SuperGreen Live brings together entrepreneurs, investors, policymakers, and activists to explore how capital and climate action can work hand in hand. With global livestreaming, VIP networking opportunities, and exclusive content, this event will empower participants to turn bold ideas into real impact. Don’t miss your chance to join tens of thousands of changemakers at the largest virtual sustainability event of the year. Learn more about sponsoring the event here. Interested in speaking? Apply here. Support our work with a tax-deductible donation here.
SuperCrowd Impact Member Networking Session: Impact (and, of course, Max-Impact) Members of the SuperCrowd are invited to a private networking session on January 27th at 1:30 PM ET/10:30 AM PT. Mark your calendar. We’ll send private emails to Impact Members with registration details.
Community Event Calendar
Successful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.
Join C-AR Annual Reporting: Requirements, Deadlines, and Lessons Learned from the Field on January 14, 2026, an informative online webinar designed to help crowdfunding issuers and professionals clearly understand C-AR annual reporting requirements, key deadlines, and real-world insights to stay compliant and prepared.
Join UGLY TALK: Women Tech Founders in San Francisco on January 29, 2026, an energizing in-person gathering of 100 women founders focused on funding strategies and discovering SuperCrowd as a powerful alternative for raising capital.
If you would like to submit an event for us to share with the 10,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.
Manage the volume of emails you receive from us by clicking here.
We use AI to help us write compelling recaps of each episode.
